(Q55463356)

12 July 2018

title

Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. (English)

1 reference

12 July 2018

1 reference

Miguel Angel Idoate

1

1 reference

12 July 2018

Ricardo Díez Valle

series ordinal

2

1 reference

12 July 2018

Jose Echeveste

series ordinal

3

1 reference

12 July 2018

Sonia Tejada

series ordinal

4

1 reference

12 July 2018

publication date

1 March 2011

1 reference

12 July 2018

published in

Neuropathology

1 reference

12 July 2018

volume

31

1 reference

12 July 2018

issue

6

1 reference

12 July 2018

page(s)

575-582

1 reference

12 July 2018

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Glioma extent of resection and its impact on patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

CNS stem cells express a new class of intermediate filament protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

CD133 identifies perivascular niches in grade II-IV astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Computed tomography and histologic limits in glial neoplasms: tumor types and selection for volumetric resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Lessons learned in the development of targeted therapy for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Nestin expression in reactive astrocytes following focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Nestin expression in reactive astrocytes of human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01202.X

10.1111/J.1440-1789.2011.01202.X

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

21355891

1 reference

12 July 2018